The main objective of this study was to compare the detection of anti-ZIKV-IgM within 6 months of age and the dynamics of anti-ZIKV-IgG antibodies over 18–24 months of age between infants with typical CZS and asymptomatic infants whose mothers had ZIKV infection during pregnancy. This evidence concerns the gene CD40LG and Zika virus infectious disease.